Skip to content
2000
Volume 16, Issue 29
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Growing evidence emphasizes that the purine nucleoside adenosine plays an active role as local regulator in airway inflammation and pulmonary diseases. The notion that increased adenosine concentrations are associated with lung inflammation indicates the importance of this signaling pathway, which involves the activation of a family of cell surface G-protein coupled receptor subtypes named as A1, A2A, A2B and A3. Recently, important progress has been made to better clarify the role of these receptors in a variety of inflammatory airway disorders including asthma. As a consequence, new molecules with high affinity and high selectivity for the human adenosine receptors subtypes designed to control the airway inflammatory component of asthma have been launched and are currently tested in clinical trials as anti-asthma treatments. With the availability of these molecules for testing in humans, the role of adenosine receptors in asthma can now be validated.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986709789178055
2009-10-01
2025-05-06
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986709789178055
Loading

  • Article Type:
    Research Article
Keyword(s): A1; A2A; A2B; A3; Adenosine; adenosine receptor; airway inflammation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test